PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit

Updated: 04/10/2020

Pipeline Type

New Drugs in Development

Phase Of Development

Phase 1

Sponsors and Collaborators

Vistagen, Epilepsy Foundation (EF)

Mechanism of Action

Glutamate

Mechanism Description

NMDA channels

Populations Tested In

Currently focused on depression but then want to expand into epilepsy indications

Special FDA Designation

Nonprofit or Government Support

Nonprofit

Nonprofit or Government Support Description

Epilepsy Foundation - Investment

Previous Presentations

Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A

Location of Clinical Trials

N/A

Clinical Trial link

Sign Up for Emails

Stay up to date with the latest epilepsy news, stories from the community, and more.